The potential of suicide plus immune gene therapy for treating osteosarcoma: The experience on canine veterinary patients

Sarcoma: Symptoms, Causes and Treatments

Volumn , Issue , 2012, Pages 107-122

  Finocchiaro, Liliana M E ^a   Spector, Agustina ^a   Rossi, Ursula A ^a   Gil Cardeza, María L ^a   Suarez, José L ^a   Riveros, María D ^a   Villaverde, Marcela S ^a   Glikin, Gerardo C ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84870964680     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (18)

1. Broadhead ML, Clark JC, Choong PF, Dass CR. Making gene therapy for osteosarcoma a reality. Expert Rev. Anticancer Ther. 2010; 10: 477-480.
2. Dow S, Elmslie R, Kurzman I, MacEwen G, Pericle F, Liggitt D. Phase I study of liposome-DNA complexes encoding the interleukin-2 gene in dogs with osteosarcoma lung metastases. Hum. Gene. Ther. 2005; 16: 937-946.
3. Finocchiaro LME, Glikin, GC. Cancer gene therapy in large animals. In New Gene Therapy and Cancer Research, W.B. Gustafsson (Ed.). Nova Science Publishers, Inc. (New York, U.S.A.). pp. 279-292 (2008). ISBN: 1-60021-969-1. a.
4. Finocchiaro LME, Glikin GC. Cytokine-enhanced vaccine and suicide gene therapy as surgery adjuvant treatments for spontaneous canine melanoma. Gene. Ther. 2008; 15: 267-276. b
5. Finocchiaro LME., Fiszman GL, Karara AL, Glikin GC. Suicide gene and cytokines combined non viral gene therapy for canine spontaneous melanoma. Cancer Gene. Ther. 2008; 15: 165-172.
6. Finocchiaro LME, Villaverde MS, Gil-Cardeza ML, Riveros MD, Glikin GC: Cytokine-enhanced vaccine and interferon-β plus suicide gene as combined therapy for spontaneous canine sarcomas. Res. Vet. Sci. 2011 91: 230-234.
7. Gil-Cardeza ML, Villaverde MS, Fiszman GL, Altamirano NA, Cwirenbaum RA, Glikin GC, Finocchiaro LME. Suicide gene therapy on spontaneous canine melanoma: correlations between in vivo tumors and their derived multicell spheroids in vitro. Gene. Ther. 2010; 17: 26-36.
8. Gorlick R, Khanna C. Osteosarcoma. J. Bone Miner. Res. 2010; 25: 683-691.
9. Hogge GS, Burkholder JK, Culp J, Albertini MR, Dubielzig RR, Keller ET, Yang NS, MacEwen EG. Development of human granulocyte-macrophage colony-stimulating factor-transfected tumor cell vaccines for the treatment of spontaneous canine cancer. Human Gene Ther. 1998; 9: 1851-1861.
10. Lascelles BD, Dernell WS, Correa MT, Lafferty M, Devitt CM, Kuntz CA, Straw RC, Withrow SJ. Improved survival associated with postoperative wound infection in dogs treated with limb-salvage surgery for osteosarcoma. Ann. Surg. Oncol. 2005; 12: 1073-1083.
11. Matsumoto K, Kubo H, Murata H, Uhara H, Takata M, Shibata S, Yasue S, Sakakibara A, Tomita Y, Kageshita T, Kawakami Y, Mizuno M. Yoshida J, Saida T. A pilot study of human interferon beta gene therapy for patients with advanced melanoma by in vivo transduction using cationic liposomes, Jpn. J. Clin. Oncol. 2008; 38: 849-856.
12. Mayer, M.N., Grier, C.K., Palliative radiation therapy for canine osteosarcoma. Can. Vet. J. 2006; 47: 707-709.
13. Mirabello L, Troisi RJ, Savage SA. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer. 2009; 115: 1531-1543.
14. Mueller F, Fuchs B, Kaser-Hotz B. Comparative biology of human and canine osteosarcoma. Anticancer Res. 2007; 27: 155-164.
15. Streck CJ, Dickson PV, Ng CY, Zhou J, Hall MM, Gray JT, Nathwani AC, Davidoff AM, Antitumor efficacy of AAV-mediated systemic delivery of interferon-beta. Cancer Gene Ther. 2006; 13: 99-106.
16. Veldwijk MR, Berlinghoff S, Laufs S, Hengge UR, Zeller WJ, Wenz F, Fruehauf S. Suicide gene therapy of sarcoma cell lines using recombinant adeno-associated virus 2 vectors. Cancer Gene Ther. 2004; 11: 577-584.
17. Withrow SJ, Wilkins RM. Cross talk from pets to people: translational osteosarcoma treatments ILAR J. 2010; 51: 208-213.
18. Yoshida J, Mizuno M, Wakabayashi T. Interferon-beta gene therapy for cancer: basic research to clinical application. Cancer Sci. 2004; 95: 858-865.